In-Person Access Only | 4.00 CME Credits & MOC Points

Please read: All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $50 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team. Industry representatives—defined as any individual who is employed by, contracted with, owns, or represents a drug, device, diagnostic, or other healthcare-related commercial entity, regardless of clinical credentials or licensure—are not permitted to attend Total Health events as general attendees. Members of industry must contact exhibits@totalhealthoncology.com

The University of Kansas Cancer Center Breast Cancer Year in Review is a condensed review of new data and advances published throughout the year and presented at key oncology meetings. It gives healthcare providers the opportunity to learn about the latest advances in oncology education and translate science into better patient care. This accredited meeting is hosted as an in-person conference only with on-demand access for registered attendees.

Program Chairs:
Priyanka Sharma, MD | The University of Kansas Cancer Center
Jennifer Klemp, PhD, MPH, MA | The University of Kansas Cancer Center

Conference Agenda
February 2027

7:45 AM
Coffee and Exhibits

8:15 AM
Conference Welcome
Priyanka Sharma, MD | The University of Kansas Cancer Center
Jennifer Klemp, PhD, MPH, MA | The University of Kansas Cancer Center

8:20 AM
Adjuvant Therapy for Hormone-Positive Breast Cancer: Matching Risk and Biology
Aditya Bardia, MD | UCLA Health

8:45 AM
Breakfast and Exhibits

9:15 AM
Non-CME Breakfast presented by Daiichi Sankyo

10:00 AM
Break and Exhibits

10:30 AM
Treatment Updates for Early and Metastatic TNBC
Reshma Mahtani, DO | Baptist Health South Florida

10:55 AM
Optimizing Locoregional Therapy in Patients with High-Risk Early-Stage Breast Cancer
Wendy Woodard, MD, PhD

11:20 AM
Monday Morning Practice Implications: Q&A and Case Discussion‍ ‍ ‍
12:05 AM
Lunch and Exhibits

12:35 PM
Non CME Lunch

1:20 PM
Break and Exhibits

1:50 PM
Emerging Role of ctDNA Monitoring in Early Breast Cancer
Adam Brufsky, MD | UPMC Hillman Cancer Center

2:15 PM
Fine-Tuning Post-CDK4/6 Inhibitor Endocrine and Targeted Therapy for Hormone-Positive Metastatic Breast Cancer

2:40 PM
Break and Exhibits

2:55 PM
Sequencing Systemic Therapy for Metastatic HER2-Positive Breast Cancer
Mothaffer Rimawi, MD | Baylor College of Medicine

3:20 PM
Monday Morning Practice Implications: Q&A and Case Discussion

4:05 PM
ADJOURN

Agenda Subject To Change. All times are CST.

• Learning Objectives

  • Determine best application of new targeted therapies in patients with early-stage and metastatic disease.

  • Discuss the advances in systemic therapy likely to change current practices for treatment of breast cancer.

  • Know how to utilize genomic tools for systemic therapy decision-making and prediction of treatment response.

  • Be familiar with germline genetic testing options for hereditary breast cancer, including advantages and disadvantages of extended panel testing.

  • Evaluate local therapy options for operable breast cancer depending on stage, and the use of neoadjuvant therapy.

  • Identify evidence-based recommendations for decreasing symptoms and improving quantity and/or quality of life in survivors.

• Accreditation Information | 7.50

  In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

  Nurses (ANCC) Credit Designation

  Amedco LLC designates this activity for a maximum of 7.50 ANCC contact hours.

  Physicians (ACCME) Credit Designation

  Amedco LLC designates this live activity for a maximum of 7.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  Pharmacists and Pharmacy Technicians (ACPE) Credit Designation

  Amedco LLC designates this activity for a maximum of 7.50 knowledge-based CPE contact hours.

  NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor.

  American Board of Internal Medicine (ABIM) MOC Credit

  Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.50 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. You must request your certificate within 45 days of the activity to meet the deadline for submission to PARS.

• What to Expect | In-Person Learners

  • Free registration for all healthcare providers

  • Expert sessions that present the most clinically relevant data, research and clinical strategies

  • Real-time discussion and debate

  • Networking with peers, colleagues and medical professionals

  • Access to the latest industry information and resources

  • Catered meals throughout the program